Michael Rehli • Dept. Internal Medicine III • University Hospital • F.-J.-Strauss Allee 11 • 93053 Regensburg
fon: **49 (0)941 944 5587    fax: **49 (0)941 944 5593

Publications

    2015

  • Joshi A, Pooley C, Freeman T, Lennartsson A, Babina M, Schmidl C, Geijtenbeek T, Michoel T, Severin J, Itoh M, Lassmann T, Kawaji H, Hayashizaki Y, Carninci P, Forrest A, Rehli M, and Hume DA. (2015). Transcription factor, promoter and enhancer utilisation in human myeloid cells. J. Leuk. Biol. ... [in press]
  • Lizio M, Harshbarger J, Shimoji H, Severin J, Kasukawa T, Sahin S, Abugessaisa I, Fukuda S, Hori F, Ishikawa-Kato S, Mungall C, Arner E, Baillie J, Bertin N, Bono H, de Hoon M, Diehl A, Dimont E, Freeman T, Fujieda K, Hide W, Kaliyaperumal R, Katayama T, Lassmann T, Meehan T, Nishikata K, Ono H, Rehli M, Sandelin A and Schultes E, ‘t Hoen PAC, Tatum Z, Thompson M, Toyoda T, Wright DW, Daub CO, Itoh M, Carninci P, Hayashizaki Y, Forrest ARR, Kawaji H and the FANTOM consortium. (2015). Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol. 2015;16:22.. Genome Biol. 16:e22 [Open Access Article]
  • Meinhardt K, Kroeger I, Bauer R, Ganss F, Ovsiy I, Rothamer J, Büttner M, Atreya I, Waldner M, Bittrich M, Lehmann CHK , Rieger MA, Beilhack A, Zeiser R, Edinger M, Dudziak D, Mackensen A, Rehli M, Ullrich E. (2015). Identification and characterization of the specific murine NK cell subset supporting graft-versusleukemia- and reducing graft-versus-host-effects. OncoImmunology. 100(1):e4-6 [in press]
  • Thomas S, Schelker R, Klobuch S, Zaiss S, Troppmann M, Rehli M, Haferlach T, Herr W, Reichle A. (2015). Biomodulatory therapy induces complete molecular remission in chemorefractory acute myeloid leukemia. Haematologica. 100(1):e4-6 [Open Access Article]
  • Peter K, Rehli M, Singer K, Renner-Sattler K, Kreutz M. (2015). Lactic acid delays the inflammatory response of human monocytes. Biochem Biophys Res Commun. 100(1):e4-6 [in press]
  • Tausendschön M, Rehli M, Dehne N, Schmidl C, Döring C, Hansmann ML, Brüne B. (2015). Genome-wide identification of hypoxia-inducible factor-1 and -2 binding sites in hypoxic human macrophages alternatively activated by IL-10. Biochim Biophys Acta. 1849(1):10-22 [Abstract]

  • 2014

  • Sonnet M, Claus R, Becker N, Zucknick M, Petersen J, Lipka DB, Oakes CC, Andrulis M, Lier A, Milsom MD, Witte T, Gu L, Kim-Wanner SZ, Schirmacher P, Wulfert M, Gattermann N, Lübbert M, Rosenbauer F, Rehli M, Bullinger L, Weichenhan D, Plass C. (2014). Early aberrant DNA methylation events in a mouse model of acute myeloid leukemia. Genome Med. 6(4):34 [Open Access Article]
  •    
  • Schmidl C, Hansmann L, Lassmann T, Balwierz PJ, Kawaji H, Itoh M, Kawai J, Nagao-Sato S, Suzuki H, Andreesen R, Hayashizaki Y, Forrest ARR, Carninci P, Hoffmann P, Edinger M, Rehli M for the FANTOM consortium. (2014). The enhancer and promoter landscape of human regulatory and conventional T cell subpopulations. Blood doi:10.1182/blood-2013-02-486944
  • Schmidl C, Renner K, Peter K, Eder R, Lassmann T, Balwierz PJ, Itoh M, Nagao-Sato S, Kawaji H, Carninci P, Suzuki H, Hayashizaki Y, Andreesen R, Hume DA, Hoffmann P, Forrest ARR, Kreutz MP, Edinger M, Rehli M. for the FANTOM consortium. (2014). Transcription and enhancer profiling in human monocyte subsets. Blood doi:10.1182/blood-2013-02-484188
  • The FANTOM Consortium. (2014). A promoter level mammalian expression atlas. Nature 507, 462–470 [Abstract] (joint first authors: Forrest ARR, Kawaji H, Rehli M, Baillie JK)
  • Andersson R, Gebhard C, Miguel-Escalada I, Hoof I, Bornholdt J, Boyd M, Chen Y, Zhao X, Schmidl C, Suzuki T, Ntini E, Arner E, Valen E, Li K, Schwarzfischer L, Glatz D, Raithel J, Lilje B, Rapin N, Bagger FO, Jørgensen M, Andersen PR, Bertin N, Rackham O, Burroughs AM, Baillie JK, Ishizu Y, Shimizu Y, Furuhata E, Maeda S, Negishi Y, Mungall CJ, Meehan TF, Lassmann T, Itoh M, Kawaji H, Kondo N, Kawai J, Lennartsson A, Daub CO, Heutink P, Hume DA, Jensen TH, Suzuki H, Hayashizaki, Y, Müller, F, Forrest ARR, Carninci P, Rehli M, Sandelin A. (2014). An atlas of active enhancers across human cell types and tissues. Nature 507, 455–461 [Abstract] (joint first authors: Andersson R, Gebhard C; corresponding authors: Forrest ARR, Carninci P, Rehli M, Sandelin A.)

  • 2013

  • Diermeier S, Németh A, Rehli M, Grummt I, Längst. (2013). Chromatin-specific regulation of mammalian rDNA transcription by clustered TTF-I binding sites. PloS Gen. 9(9):e1003786 [Open Access Article]
  • Dutruel C, Bergmann F, Rooman I, Zucknick M, Weichenhan D, Rachakonda PS, Bauer A, Giese N, Hong C, Xie H, Costello J, Hoheisel J, Kumar R, Rehli M, Schirmacher P, Werner J, Plass C, Popanda O, Schmezer P. (2013). Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development. Oncogene [Abstract]
  • Gottfried E, Lang SA, Renner K, Bosserhoff A, Gronwald W, Rehli M, Einhell S, Gedig I, Singer K, Seilbeck A, Mackensen A, Grauer O, Hau P, Dettmer K, Andreesen R, Oefner PJ, Kreutz M. (2013) New Aspects of an Old Drug - Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells. PLoS One 8(7): e66987 [Open Access Article]
  • Klug M, Schmidhofer S, Gebhard C, Andreesen R, Rehli M. (2013) 5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes. Genome Biol. 14, R46. [Open Access Article]
  • Pham TH, Minderjahn J, Schmidl C, Hoffmeister H, Schmidhofer S, Chen W, Längst G, Benner C, Rehli, M (2013) Mechanisms of in-vivo binding site selection of the hematopoietic master transcription factor PU.1 Nucleic Acids Res. 41:6391-6402. [Open Access Article]
  • Dehan P, Canon C, Trooskens G, Rehli M, Munaut C, Van Criekinge W, Delvenne P. (2013). Expression of type 2 orexin receptor in human endometrium and its epigenetic silencing in endometrial cancer. J Clin Endocrinol Metab. 98,1549-57 [Abstract]
  • Sonnet M, Baer C, Rehli M, Weichenhan D, Plass C. (2013). Enrichment of methylated DNA by methyl-CpG immunoprecipitation. Methods Mol Biol. 971,201-12 [Abstract]

  • 2012

  • Faryna M, Konermann C, Aulmann S, Bermejo JL, Brugger M, Diederichs S, Rom J, Weichenhan D, Claus R, Rehli M, Schirmacher P, Sinn HP, Plass C, Gerhauser C. (2012). Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis. FASEB J. 26, 4937-50 [Abstract]
  • Baer C, Claus R, Frenzel LP, Zucknick M, Park YJ, Gu L, Weichenhan D, Fischer M, Pallasch CP, Herpel E, Rehli M, Byrd JC, Wendtner CM, Plass C. (2012). Extensive Promoter DNA Hypermethylation and Hypomethylation Is Associated with Aberrant MicroRNA Expression in Chronic Lymphocytic Leukemia. Cancer Res 72, 3775-3785 [Abstract]
  • Pham TH, Benner C, Lichtinger M, Schwarzfischer L, Hu Y, Andreesen R, Chen W, Rehli M. (2012). Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states. Blood 119, e161-71 [Abstract]
  • Hansmann L, Schmidl C, Kett J, Steger L, Andreesen R, Hoffmann P, Rehli M, Edinger M. (2012). Dominant Th2 differentiation of human regulatory T cells upon loss of FOXP3 expression. J Immunol. 188, 1275-1282. [Abstract]
  • Byun CJ, Seo J, Jo SA, Park YJ, Klug M, Rehli M, Park MH, Jo I. (2012). DNA methylation of the 5'-untranslated region at +298 and +351 represses BACE1 expression in mouse BV-2 microglial cells. Biochem Biophys Res Commun. 417, 387-392. [Abstract]

  • 2011

  • Kuhmann C, Weichenhan D, Rehli M, Plass C, Schmezer P, Popanda O. (2011). DNA methylation changes in cells regrowing after fractioned ionizing radiation. Radiother Oncol. 101, 116-121. [Abstract]
  • Schmidl C, Hansmann L, Andreesen, R, Edinger M, Hoffmann P, Rehli M. (2011). Epigenetic reprogramming of the RORC locus during in vitro expansion is a distinctive feature of human memory but not naïve Treg cells. Eur J Immunol. 41, 1491-98. [Abstract]
  • Fragale A, Stellacci E, Ilari R, Remoli AL, Lanciotti A, Perrotti E, Shytaj I, Orsatti R, Lawrence HR, Lawrence NJ, Wu J, Rehli M, Ozato K, Battistini A. (2011). Critical Role of IRF-8 in Negative Regulation of TLR3 Expression by Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase-2 Activity in Human Myeloid Dendritic Cells. J Immunol. 186, 1951-62. [Abstract]
  • Kawaji H, Severin J, Lizio M, Forrest AR, van Nimwegen E, Rehli M, Schroder K, Irvine K, Suzuki H, Carninci P, Hayashizaki Y, Daub CO. (2011). Update of the FANTOM web resource: from mammalian transcriptional landscape to its dynamic regulation. Nucleic Acids Res. 39, D856-60. [Abstract]

  • 2010

  • Langmann T, Rehli M. (2010). Immunobiology. Editorial. Immunobiology. 215, 673.
  • El Chartouni C, Rehli M. (2010). Comprehensive analysis of TLR4-induced transcriptional responses in interleukin 4-primed mouse macrophages. Immunobiology. 215, 780-787. [Abstract]
  • El Chartouni C, Schwarzfischer L, Rehli M. (2010). Interleukin-4 induced interferon regulatory factor (Irf) 4 participates in the regulation of alternative macrophage priming. Immunobiology. 215, 821-825. [Abstract]
  • Kubosaki A, Lindgren G, Tagami M, Simon C, Tomaru Y, Miura H, Suzuki T, Arner E, Forrest AR, Irvine KM, Schroder K, Hasegawa Y, Kanamori-Katayama M, Rehli M, Hume DA, Kawai J, Suzuki M, Suzuki H, Hayashizaki Y. (2010). The combination of gene perturbation assay and ChIP-chip reveals functional direct target genes for IRF8 in THP-1 cells. Mol Immunol. 47, 2295-2302. [Abstract]
  • Klug M, Heinz S, Gebhard C, Schwarzfischer L, Krause SW, Andreesen R, Rehli M. (2010). Active DNA demethylation in human postmitotic cells correlates with activating histone modifications, but not transcription levels. Genome Biol. 11, R63. [Open Access Article]     Research Highlight in Nature 466, 163.
  • Hansmann L, Schmidl C, Boeld TJ, Andreesen, R, Hoffmann P, Rehli M, Edinger M. (2010). Isolation of intact genomic DNA from FOXP3-sorted human regulatory T cells for epigenetic analyses. Eur J Immunol. 40, 1510-1512. [No Abstract]
  • Gebhard C., Benner C., Ehrich M., Schwarzfischer L., Schilling E., Klug M., Dietmaier W., Thiede C., Holler E., Andreesen R., Rehli M. (2010). General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells. Cancer Res. 70, 1398-1407. [Abstract]
  • Yokota S., Okabayashi T., Rehli M., Fujii N., Amano K. (2010). Helicobacter pylori lipopolysaccharides upregulate toll-like receptor 4 expression and proliferation of gastric epithelial cells via the MEK1/2-ERK1/2 mitogen-activated protein kinase pathway. Infect Immun. 78, 468-476 [Abstract]
  • El Chartouni C, Benner C, Eigner M, Lichtinger M, Rehli M. (2010). Transcriptional effects of Colony-stimulating factor-1 in mouse macrophages. Immunobiology. 215, 466-474. [Abstract]

  • 2009

  • Schilling E, El Chartouni C, Rehli M. (2009). Allele-specific DNA methylation in mouse strains is mainly determined by cis-acting sequences. Genome Res. 19, 2028-35 [Abstract]
  • Weil T, Korb J, Rehli M. (2009). Comparison of queen-specific gene expression in related lower termite species. Mol Biol Evol. 26, 1841-50. [Abstract]
  • Schmidl C, Klug M, Boeld T, Andreesen R, Hoffmann P, Edinger M, Rehli M. (2009). Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. Genome Res. 19, 1165-74. [Abstract]
  • Korb J, Weil T, Hoffmann K, Foster KR, Rehli M. (2009). A gene necessary for reproductive suppression of termites. Science 324, 758 [Abstract]
  • The FANTOM Consortium. (2009). The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nat Genetics 41, 553-62. [Abstract]
  • Mueller DW, Rehli M, Bosserhoff AK. (2009). miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J. Invest. Dermatol. 129, 1740-51. [Article]
  • Weigelt K, Lichtinger M, Rehli M, Langmann T. (2009). Transcriptomic profiling identifies a PU.1 regulatory network in macrophages. Biochem Biophys Res Commun. 320, 308-312. [Abstract]
  • Voelkl S, Moore TV, Rehli M, Nishimura MI, Mackensen A, Fischer K. (2009). Characterization of MHC class-I restricted TCRalphabeta+ CD4- CD8- double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccination. Cancer Immunol Immunother. 58,709-718. [Abstract]

  • 2008

  • Bhat KP, Pelloski CE, Zhang Y, Kim SH, deLaCruz C, Rehli M., Aldape KD. (2008). Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2. FEBS Lett. 582, 3193-3200. [Abstract]
  • Gottfried E, Kunz-Schughart LA, Weber A, Rehli M, Peuker A, Müller A, Kastenberger M, Brockhoff G, Andreesen R, Kreutz M. (2008). Expression of CD68 in non-myeloid cell types. Scand. J Immunol. 67, 453-463. [Abstract]

  • 2007

  • Weigelt K, Ernst W, Walczak Y, Ebert S, Loenhardt T, Klug M, Rehli M, Weber BH, Langmann T. (2007). Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation. J. Leukoc. Biol. 82, 1564-1574. [Abstract]
  • Lichtinger M, Ingram R, Hornef M, Bonifer C, Rehli M. (2007). Transcription factor PU.1 controls transcription start site positioning and alternative TLR4 promoter usage. J. Biol. Chem. 282, 26874-83. [Abstract]
  • Weil T, Rehli M, Korb J. (2007). Molecular basis for the reproductive division of labour in a lower termite. BMC Genomics 8, 198. [Abstract]
  • Schilling E, Rehli M. (2007) Global, comparative analysis of tissue-specific promoter CpG methylation. Genomics 90, 314-23. [Abstract]
  • Pham TH, Langmann S, Schwarzfischer L, El Chartouni C, Lichtinger M, Klug M, Krause SW, Rehli M. (2007). CCAAT enhancer-binding protein beta regulates constitutive gene expression during late stages of monocyte to macrophage differentiation. J Biol Chem. 282, 21924-33. [Abstract]
  • Schroder K, Lichtinger M, Irvine KM, Brion K, Trieu A, Ross IL, Ravasi T, Stacey KJ, Rehli M, Hume DA, Sweet MJ. (2007). PU.1 and ICSBP control constitutive and IFN-gamma-regulated Tlr9 gene expression in mouse macrophages. J Leukoc Biol. 81, 1577-1590. [Abstract]

  • 2006

  • Gebhard C, Schwarzfischer L, Pham TH, Andreesen R, Mackensen A, Rehli M. (2006). Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR. Nucleic Acids Res. 34, e82. [Abstract]
  • Klug M, Rehli M (2006). Functional Analysis of Promoter CPG-Methylation using a CpG-Free Luciferase Reporter Vector. Epigenetics 1, 127-130. [Abstract]
  • Gebhard C, Schwarzfischer L, Pham TH, Schilling E, Klug M, Andreesen R, Rehli M. (2006) Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Cancer Res. 66, 6118-28.[Abstract]

  • 2005

  • Rehli M, Sulzbacher S, Pape S, Ravasi T, Wells CA, Heinz S, Sollner L, El Chartouni C, Krause SW, Steingrimsson E, Hume DA, Andreesen R (2005). Transcription factor Tfec contributes to the IL-4-inducible expression of a small group of genes in mouse macrophages including the granulocyte colony-stimulating factor receptor. J. Immunol. 174, 7111-22. [Abstract]

  • 2003

  • Zaiss M, Hirtreiter C, Rehli M, Rehm A, Kunz-Schughart LA, Andreesen R, Hennemann B. (2003). CD84 expression on human hematopoietic progenitor cells. Exp Hematol. 31, 798-805. [Abstract]
  • Rehli M, Niller HH, Ammon C, Langmann S, Schwarzfischer L, Andreesen R, Krause SW (2003). Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation. J. Biol. Chem. 278, 44058-67. [Free Article]
  • Heinz S, Haehnel V, Karaghiosoff M, Schwarzfischer L, Muller M, Krause SW, Rehli M. (2003). Species-specific regulation of toll-like receptor 3 genes in men and mice. J. Biol. Chem. 278, 21502-21509 [Free Article]

  • 2002

  • Timblin B, Rehli M, Skidgel RA. (2002). Structural characterization of the human carboxypeptidase D gene and its promoter. Int Immunopharmacol. 2, 1907-1917 [Abstract]
  • Beutler B, Rehli M. (2002). Evolution of the TIR, tolls and TLRs: functional inferences from computational biology. Curr Top Microbiol Immunol. 270, 1-21
  • Rehli, M. (2002). Of mice and men: species variations of Toll-like receptor expression. Trends in Immunol. 23, 375-8 [Abstract]
  • Hähnel, V., Schwarzfischer, L., Fenton, M.J., Rehli, M. (2002). Transcriptional regulation of the human Toll-like receptor 2 gene in monocytes and macrophages. J. Immunol. 168, 5629-37 [Free Article]
  • Heinz, S., Krause, S.W., Gabrielli, F., Wagner, H.M., Andreesen, R. and Rehli, M. (2002). Genomic organization of the human Hep27 gene: alternative promoter usage in HepG2 cells and monocyte-derived dendritic cells. Genomics 79, 608-15 [Abstract]
  • Li, J., Rehli, M., Timblin, B., Tan, F., Krause, S.W., and Skidgel, R.A. (2002). Structural Characterization of the Human Carboxypeptidase M Gene. Identification of a Proximal GC-Rich Promoter and a Unique Alternative Distal Promoter that Consists of Repetitive Elements. Gene 284, 189-202. [Abstract]
  • Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, Stevenson MA, Calderwood SK. (2002). Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J. Biol Chem. 277, 15028-15034 [Free Article]
  • Mansky, K.C., Sulzbacher, S., Purdom, G., Nelson, L., Hume, D.A., Rehli, M., Ostrowski, M.C. (2002). The microphthalmia transcription factor and the related helix-loop-helix zipper factors TFE-3 and TFE-C collaborate to activate TRAP gene expression in murine osteoclasts. J. Leuk. Biol. 71, 304-310 [Free Article]

  • 2000

  • Holtrich U, Wolf G, Yuan J, Bereiter-Hahn J, Karn T, Weiler M, Kauselmann G, Rehli M, Andreesen R, Kaufmann M, Kuhl D, Strebhardt K. (2000). Adhesion induced expression of the serine/threonine kinase Fnk in human macrophages. Oncogene 19, 4832-4839. [Free Article]
  • Rehli M, Krause SW, Andreesen R.(2000). The membrane-bound ectopeptidase CPM as a marker of macrophage maturation in vitro and in vivo. Adv Exp Med Biol. 477, 205-216.
  • Rehli, M, Poltorak,A, Schwarzfischer, L, Krause, SW, Andreesen, R, Beutler, B. (2000). PU.1 and interferon consensus sequence binding protein (ICSBP) regulate the myeloid expression of the human Toll-like receptor 4 gene. J. Biol. Chem. 275, 9773-81. [Free Article]
  • Krause SW, Rehli M, Heinz S, Ebner R, Andreesen R. (2000). Characterization of MAX.3 antigen, a glycoprotein expressed on mature macrophages, dendritic cells and blood platelets: identity with CD84. Biochem J. 346, 729-36. [Free Article]

  • 1999

  • Rehli, M, Den Elzen, N, Cassady, AI, Ostrowski, MC, Hume, DA. (1999).Cloning and characterization of the murine genes for bHLH-ZIP transcription factors TFEC and TFEB reveals a common gene organization for all MiT-subfamily members. Genomics 56, 111-120. [Abstract]
  • Rehli, M, Lichanska, A, Cassady, AI, Ostrowski, MC, Hume, DA. (1999). TFEC is a macrophage-restricted member of the microphthalmia-TFE Subfamily of Basic Helix-Loop-Helix Leucine Zipper Transcription factors. J. Immunol. 162, 1559-1565. [Abstract]

  • 1998

  • Krause SW, Rehli M, Andreesen R. (1998). Carboxypeptidase M as a marker of macrophage maturation. Immunol Rev. 161, 119-127. [NA]
  • Ammon C, Kreutz M, Rehli M, Krause SW, Andreesen R. (1998). Platelets induce monocyte differentiation in serum-free coculture. J Leuk Biol. 63, 469-476. [Free Article]

  • 1997

  • Tan F, Rehli M, Krause SW, Skidgel RA. (1997). Sequence of human carboxypeptidase D reveals it to be a member of the regulatory carboxypeptidase family with three tandem active site domains. Biochem J. 327, 81-87. [Article]
  • Rehli, M., Krause, S.W., Andreesen, R. (1997). Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics 43, 221-225. [Abstract]
  • Fritsche J, Rehli M, Krause SW, Andreesen R, Kreutz M. (1997). Molecular cloning of a 1alpha,25-dihydroxyvitamin D3-inducible transcript (DDVit 1) in human blood monocytes. Biochem Biophys Res Commun. 43, 221-225. [Abstract]
  • McGwire GB, Tan F, Michel B, Rehli M, Skidgel RA. (1997). Identification of a membrane-bound carboxypeptidase as the mammalian homolog of duck gp180, a hepatitis B virus-binding protein. Life Sci. 60, 715-724. [Abstract]

  • 1996

  • Krause, SW, Rehli, M, Paulauskis, J, Schwarzfischer, L, Kreutz, M, Andreesen, R (1996). Cloning of maturation-associated cDNAs of in vitro differentiated macrophages by differential screening. J. Leuk. Biol. 60, 540-545. [Free Article]
  • Rehli M, Luger K, Beier W, Falk W. (1996). Molecular cloning and expression of mouse procalcitonin. Biochem Biophys Res Commun. 226, 420-425. [Abstract]
  • Konur A, Krause SW, Rehli M, Kreutz M, Andreesen R. (1996). Human monocytes induce a carcinoma cell line to secrete high amounts of nitric oxide. J.Immunol. 157, 2109-2015. [Abstract]

  • 1995

  • Rehli, M, Krause, SW, Kreutz, M, Andreesen, R. (1995). Carboxypeptidase M is identical to MAX.1 antigen and its expression is associated with monocyte to macrophage differentiation. J. Biol. Chem. 270, 15644-15649. [Free Article]
  • Rehli, M, Krause, SW, Schwarzfischer, L, Kreutz, M, Andreesen, R. (1995). Molecular cloning of a novel macrophage maturation associated transcript encoding a protein with several potential transmembrane domains. Biochem. Biophys. Res. Com. 217, 661-667. [Abstract]